FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
31/10/2023
Voltar para busca
Dado oficial do USPTO
SIGI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
31/10/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
9, 10
Data de depósito
22/07/2021
Data de registro
11/07/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/07/2023
Última transação
11/07/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
33
Localização do titular
CH
Examinador
MAHMOUDI, MARIAM
Unidade examinadora
M60
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized word "Sigi" in white appearing within a circle outlined in white; all of the foregoing appearing on a blue background.
Titulares e representantes
Titulares
AMF Medical SA
Representantes
Louis K. Ebling Thompson Hine LLP
Classificação técnica
Classes Nice
Classe 9Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable and recorded software for use in medication delivery systems for controlling medicament delivery in the field of diabetes management; downloadable software for use in infusion patch pump systems for diabetes management; downloadable software in the form of applications for mobile telephoneslaptops and portable electronic devicessaid software for use in user authentication and secure data transmission online and controlling pumps for medical use
Classe 10
Medical fluid injectorsinjectors for transcutaneous delivery of medication including insulin; pumps for medical usewearable patch pumps sold empty for transcutaneously delivering medication for diabetes management; replacement parts and accessories specifically adapted for pumps for medical usereplacement caps for microdosingcannula applicatorsadhesive padstranscutaneous cannulas; medicine administering devicesinfusion and injection devices for administering drugs; portable subcutaneous drug delivery devicesdrug delivery ports and pumps for delivering drugs beneath the skin; infusion pumps; devices for diabetes managementinsulin patch pumps sold empty; insulin pumps
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/10/2023
FIMP
FINAL DISPOSITION PROCESSED
11/10/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/10/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/07/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
11/07/2023
GPNX
NOTIFICATION PROCESSED BY IB
16/05/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
25/04/2023
PUBO
PUBLISHED FOR OPPOSITION
25/04/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
05/04/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
05/04/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/04/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
04/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
21/03/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
21/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
21/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
21/03/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/03/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/03/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/02/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/02/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/02/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/02/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/01/2023
GNFR
FINAL REFUSAL E-MAILED
04/01/2023
CNFR
FINAL REFUSAL WRITTEN
04/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/11/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
23/11/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
24/09/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
26/08/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
26/08/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
26/08/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
26/08/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
26/08/2022
RFNT
REFUSAL PROCESSED BY IB
22/06/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
26/05/2022
RFRR
REFUSAL PROCESSED BY MPU
26/05/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
23/04/2022
CNRT
NON-FINAL ACTION WRITTEN
22/04/2022
DOCK
ASSIGNED TO EXAMINER
18/04/2022
MAFR
APPLICATION FILING RECEIPT MAILED
19/10/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/10/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
14/10/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SIGI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.